Diabetes research and clinical practice

Higher heart and metabolism risk scores after infection are linked to greater chances of long COVID over time

Updated

Abstract

The Cardiometabolic Disease Staging (CMDS) model was used to evaluate changes in cardiometabolic risk related to COVID-19 infection.

  • Changes in cardiometabolic risk may be linked to the development of Long COVID.
  • The CMDS model quantitatively measures the severity of cardiometabolic disease.
  • COVID-19 infection could alter cardiometabolic risk profiles in affected individuals.
  • Observations suggest a potential relationship between cardiometabolic risk and Long COVID outcomes.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free